qlt inc (QLT:Toronto)

Executive Profile*

Background*

Dr. Geoffrey F. Cox, PhD is a Partner of Red Sky Partners LLC. Dr. Cox served as Chairman, Chief Executive Officer and President of rEVO Biologics (formerly, GTC Biotherapeutics Inc.) from July 2001 to June 15, 2010. Dr. Cox served as the Chairman of Aronex Pharmaceuticals Inc. from 1997 to June 2001 and its Chief Executive Officer since November 1997. He served as Senior Vice President of Operations at Genzyme Corp. since 1988 and an Executive Vice President of Operations ... responsible for operations and the pharmaceutical, diagnostic and genetics business units until 1997. In 1984, Dr. Cox joined Genzyme in the UK as Operations Director and also served as a Managing Director of Genzyme's UK operations in Haverhill and Maidstone in 1986. Dr. Cox served as a General Manager of U.K. manufacturing operations of Gist-Brocades. He has over 35 years of pharmaceutical and biotechnology experience in a broad range of senior management positions in operations management, as the Chief Executive Officer and as a member of the board of public companies. He serves as Chairman of Alphavax Inc. He serves as the Chairman of MassBio. Dr. Cox served as the Non Executive Chairman of Nabi Biopharmaceuticals since February 15, 2007. He has been an Independent Director of QLT Inc. since June 4, 2012. He serves as an Independent Director of Gallus Biopharmaceuticals LLC. Dr. Cox serves on the Board of the Massachusetts Biotechnology Council. He serves as a Non-Executive Director of Rodman & Renshaw Elixir Securities Limited. He serves Non-Executive Director of Biota Pharmaceuticals, Inc. He serves as a Non-Executive Director of Biota Holdings Limited. He served as a Director of the Biotechnology Industry Organization. He served as a Director of Nabi Biopharmaceuticals since December 2000. He served as a Director of GTC Biotherapeutics Inc. from May 2001 to June 15, 2010. He served as Directore of rEVO Biologics from May 2005 to June 15, 2010. He served as a Director of Aronex Pharmaceuticals Inc. since January 1994. Dr. Cox received a Ph.D. in Biochemistry from the University of East Anglia U.K. and a B.Sc. (Hons) in Biochemistry from the University of Birmingham U.K.

Report Data Issue

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Recently Viewed
QLT:CN	C$8.45 CAD	-0.03

COMPETITOR COMPENSATION